Enver Cagri Izgu, PhD, from the School of Arts and Sciences at Rutgers-New Brunswick, and his team will use a nearly $2 million NIH grant to develop diverse molecules with “programmed functionality” to address the fundamental challenges in therapeutic approaches that rely on modulating gene expression.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.